A survey carried out by CEVA Animal Health, manufacturer of the pheromonatherapy products D.A.P.® and Feliway®, has revealed that 94 per cent of veterinary professionals believe that owners' lifestyles are the major cause of behavioural problems…
New research amongst veterinary professionals conducted by CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has revealed that pet owners may be unintentionally fuelling their pets' noise phobias in the run up to the fireworks' season…
CEVA Animal Health has announced the results of a survey which found that nearly half a million UK cat and dog owners never go on holiday for fear of upsetting their pet's routine.
In addition, the research revealed that half³ of pet owners who do…
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction…